Literature DB >> 8425246

Hyperkalaemia: a complication of warm heart surgery.

Y J Kao1, T Mian, S Kleinman, G B Racz.   

Abstract

A case is presented of hyperkalaemia (13.6 mEq.L-1) occurring during cardiopulmonary bypass using warm blood cardioplegia (K+ 40-60 mEq.L-1). Treatment with epinephrine, calcium chloride, sodium bicarbonate, and furosemide reduced K+ to 6.5 mEq.L-1 within 30 min and myocardial performance was enhanced with amrinone and cardiac rhythm was controlled with A-V segmental pacing. It is believed that the hyperkalaemia resulted from a combination of the surgical procedure (mitral valve replacement) and the use of warm cardioplegia. The purpose of this report is to increase the awareness of the possibility of hyperkalaemia with warm cardioplegia and to describe a successful therapeutic regimen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425246     DOI: 10.1007/BF03009322

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  Oxygenated cardioplegia: blood is a many splendored thing.

Authors:  G D Buckberg
Journal:  Ann Thorac Surg       Date:  1990-08       Impact factor: 4.330

2.  Myocardial protection by retrograde cardioplegia in arterial switch operation.

Authors:  K Yonenaga; H Yasui; H Kado; Y Nakamura; Y Shiokawa; T Yamamoto; K Miyamoto
Journal:  Ann Thorac Surg       Date:  1990-08       Impact factor: 4.330

3.  Continuous retrograde blood cardioplegia.

Authors:  F P Sutter; S M Goldman; M Clancy; J M Mitchell; A Garwood; S King; J F Gallagher
Journal:  Ann Thorac Surg       Date:  1991-01       Impact factor: 4.330

4.  Ischemic contracture of the heart: "stone heart".

Authors:  D A Cooley; G J Reul; D C Wukasch
Journal:  Am J Cardiol       Date:  1972-04       Impact factor: 2.778

5.  Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia.

Authors:  K H Teoh; G T Christakis; R D Weisel; S E Fremes; D A Mickle; A D Romaschin; R S Harding; J Ivanov; M M Madonik; I M Ross
Journal:  J Thorac Cardiovasc Surg       Date:  1986-06       Impact factor: 5.209

6.  Comparison of blood-based and asanguineous cardioplegic solutions administered at 4 degrees C. An ultrastructural morphometric study in the dog.

Authors:  R A Axford-Gatley; G J Wilson; C M Feindel
Journal:  J Thorac Cardiovasc Surg       Date:  1990-09       Impact factor: 5.209

7.  Intraoperative protection of the myocardium. Introduction to the symposium.

Authors:  L L Michaelis
Journal:  Ann Thorac Surg       Date:  1975-07       Impact factor: 4.330

8.  A clinical trial of blood and crystalloid cardioplegia.

Authors:  S E Fremes; G T Christakis; R D Weisel; D A Mickle; M M Madonik; J Ivanov; R Harding; S J Seawright; S Houle; P R McLaughlin
Journal:  J Thorac Cardiovasc Surg       Date:  1984-11       Impact factor: 5.209

9.  Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.

Authors:  A Blumberg; P Weidmann; S Shaw; M Gnädinger
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

10.  Retrograde coronary sinus cardioplegia for aortic valve operations: a clinical report on 500 patients.

Authors:  P Menasché; J B Subayi; A Piwnica
Journal:  Ann Thorac Surg       Date:  1990-04       Impact factor: 4.330

View more
  2 in total

1.  Hyperkalaemia after warm heart surgery.

Authors:  C I Yam; M A Fox; B M Fabri
Journal:  Can J Anaesth       Date:  1993-09       Impact factor: 5.063

2.  Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution.

Authors:  Sarkis M Minasian; Michael M Galagudza; Yuri V Dmitriev; Dmitry I Kurapeev; Timur D Vlasov
Journal:  J Cardiothorac Surg       Date:  2013-04-02       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.